News Image

New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer

Provided By GlobeNewswire

Last update: May 2, 2025

Additionally, an expert physician panel convened by EndoscopyNow will host a product theater on Sunday, May 4, at 2:45 p.m. Pacific Time, titled, “The Time is Now: A Clinical Practice Model to Help Prevent Progression from Barrett's to EAC”

Read more at globenewswire.com

CASTLE BIOSCIENCES INC

NASDAQ:CSTL (12/18/2025, 8:15:48 PM)

After market: 39.6 0 (0%)

39.6

-0.06 (-0.15%)



Find more stocks in the Stock Screener

Follow ChartMill for more